Revance Therapeutics Statistics
Total Valuation
WEN has a market cap or net worth of $1.91 billion. The enterprise value is $5.66 billion.
| Market Cap | 1.91B |
| Enterprise Value | 5.66B |
Important Dates
The next confirmed earnings date is Friday, August 8, 2025, before market open.
| Earnings Date | Aug 8, 2025 |
| Ex-Dividend Date | Jun 2, 2025 |
Share Statistics
WEN has 192.03 million shares outstanding. The number of shares has decreased by -2.50% in one year.
| Current Share Class | 192.03M |
| Shares Outstanding | 192.03M |
| Shares Change (YoY) | -2.50% |
| Shares Change (QoQ) | -1.67% |
| Owned by Insiders (%) | 9.45% |
| Owned by Institutions (%) | 76.49% |
| Float | 147.40M |
Valuation Ratios
The trailing PE ratio is 10.58 and the forward PE ratio is 10.46. WEN's PEG ratio is 2.00.
| PE Ratio | 10.58 |
| Forward PE | 10.46 |
| PS Ratio | 0.91 |
| Forward PS | 0.85 |
| PB Ratio | 14.98 |
| P/TBV Ratio | n/a |
| P/FCF Ratio | 7.77 |
| P/OCF Ratio | 5.61 |
| PEG Ratio | 2.00 |
Enterprise Valuation
The stock's EV/EBITDA ratio is 11.05, with an EV/FCF ratio of 23.01.
| EV / Earnings | 29.54 |
| EV / Sales | 2.53 |
| EV / EBITDA | 11.05 |
| EV / EBIT | 15.38 |
| EV / FCF | 23.01 |
Financial Position
The company has a current ratio of 1.49, with a Debt / Equity ratio of 31.35.
| Current Ratio | 1.49 |
| Quick Ratio | 1.16 |
| Debt / Equity | 31.35 |
| Debt / EBITDA | 7.97 |
| Debt / FCF | 16.59 |
| Interest Coverage | 2.39 |
Financial Efficiency
Return on equity (ROE) is 90.40% and return on invested capital (ROIC) is 5.33%.
| Return on Equity (ROE) | 90.40% |
| Return on Assets (ROA) | 4.55% |
| Return on Invested Capital (ROIC) | 5.33% |
| Return on Capital Employed (ROCE) | 8.20% |
| Revenue Per Employee | $154,152 |
| Profits Per Employee | $13,214 |
| Employee Count | 14,500 |
| Asset Turnover | 0.44 |
| Inventory Turnover | 235.17 |
Taxes
In the past 12 months, WEN has paid $78.28 million in taxes.
| Income Tax | 78.28M |
| Effective Tax Rate | 29.01% |
Stock Price Statistics
The stock price has decreased by -41.17% in the last 52 weeks. The beta is 0.34, so WEN's price volatility has been lower than the market average.
| Beta (5Y) | 0.34 |
| 52-Week Price Change | -41.17% |
| 50-Day Moving Average | 11.21 |
| 200-Day Moving Average | 14.58 |
| Relative Strength Index (RSI) | 35.72 |
| Average Volume (20 Days) | 7,537,664 |
Short Selling Information
The latest short interest is 20.18 million, so 10.51% of the outstanding shares have been sold short.
| Short Interest | 20.18M |
| Short Previous Month | 21.23M |
| Short % of Shares Out | 10.51% |
| Short % of Float | 13.69% |
| Short Ratio (days to cover) | 2.50 |
Income Statement
In the last 12 months, WEN had revenue of $2.24 billion and earned $191.60 million in profits. Earnings per share was $0.94.
| Revenue | 2.24B |
| Gross Profit | 787.74M |
| Operating Income | 368.03M |
| Pretax Income | 277.53M |
| Net Income | 191.60M |
| EBITDA | 512.29M |
| EBIT | 368.03M |
| Earnings Per Share (EPS) | $0.94 |
Balance Sheet
The company has $335.26 million in cash and $4.08 billion in debt, giving a net cash position of -$3.75 billion or -$19.51 per share.
| Cash & Cash Equivalents | 335.26M |
| Total Debt | 4.08B |
| Net Cash | -3.75B |
| Net Cash Per Share | -$19.51 |
| Equity (Book Value) | 130.24M |
| Book Value Per Share | 0.67 |
| Working Capital | 210.69M |
Cash Flow
In the last 12 months, operating cash flow was $340.74 million and capital expenditures -$94.71 million, giving a free cash flow of $246.02 million.
| Operating Cash Flow | 340.74M |
| Capital Expenditures | -94.71M |
| Free Cash Flow | 246.02M |
| FCF Per Share | $1.28 |
Margins
Gross margin is 35.24%, with operating and profit margins of 16.46% and 8.57%.
| Gross Margin | 35.24% |
| Operating Margin | 16.46% |
| Pretax Margin | 12.07% |
| Profit Margin | 8.57% |
| EBITDA Margin | 22.92% |
| EBIT Margin | 16.46% |
| FCF Margin | 11.01% |
Dividends & Yields
This stock pays an annual dividend of $1.00, which amounts to a dividend yield of 10.15%.
| Dividend Per Share | $1.00 |
| Dividend Yield | 10.15% |
| Dividend Growth (YoY) | -11.00% |
| Years of Dividend Growth | n/a |
| Payout Ratio | 94.57% |
| Buyback Yield | 2.50% |
| Shareholder Yield | 12.54% |
| Earnings Yield | 10.02% |
| FCF Yield | 12.86% |
Analyst Forecast
The average price target for WEN is $15.08, which is 51.41% higher than the current price. The consensus rating is "Hold".
| Price Target | $15.08 |
| Price Target Difference | 51.41% |
| Analyst Consensus | Hold |
| Analyst Count | 18 |
| Revenue Growth Forecast (5Y) | n/a |
| EPS Growth Forecast (5Y) | n/a |
Fair Value
There are several formulas that can be used to estimate the intrinsic value of a stock.
| Lynch Fair Value | |
| Lynch Upside | |
| Graham Number | |
| Graham Upside |
Stock Splits
The last stock split was on September 5, 2003. It was a forward split with a ratio of 3:1.
| Last Split Date | Sep 5, 2003 |
| Split Type | Forward |
| Split Ratio | 3:1 |
Scores
WEN has an Altman Z-Score of 1.3 and a Piotroski F-Score of 6. A Z-score under 3 suggests an increased risk of bankruptcy.
| Altman Z-Score | 1.3 |
| Piotroski F-Score | 6 |